enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.42
+0.28 (4.56%)
At close: Dec 27, 2024, 4:00 PM
6.55
+0.13 (2.02%)
After-hours: Dec 27, 2024, 4:50 PM EST
enGene Holdings Employees
As of October 31, 2023, enGene Holdings had 33 total employees, including 31 full-time and 2 part-time employees.
Employees
33
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,670,970
Market Cap
327.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2023 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 1,029 |
| Viemed Healthcare | 996 |
| Cerus | 637 |
| CVRx, Inc. | 200 |
| Nyxoah | 147 |
| Senseonics Holdings | 132 |
| Sanara MedTech | 108 |
| Aclaris Therapeutics | 91 |
ENGN News
- 8 days ago - enGene Reports Full Year 2024 Financial Results and Provides a Business Update - Business Wire
- 12 days ago - enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook - Seeking Alpha
- 4 weeks ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - enGene to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - Business Wire
- 2 months ago - enGene Announces $60 Million Private Placement Financing - Business Wire
- 2 months ago - enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer - Business Wire
- 3 months ago - enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire